Kevin Roesser

Kevin Roesser

Associate

Kevin Roesser is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he focuses on corporate and securities law, including emerging companies, capital markets, mergers and acquisitions, corporate governance, SEC compliance, and 1934 Act issues.

Experience

Education

J.D., Santa Clara University School of Law
B.A., Philosophy – Ethics and Public Policy, University of California, Santa Barbara

Admissions

State Bar of California

Credentials

Education

J.D., Santa Clara University School of Law
B.A., Philosophy – Ethics and Public Policy, University of California, Santa Barbara

Admissions

State Bar of California

Corporate

Recent Insights

Client Highlights

On April 6, 2026, Neurocrine Biosciences and Soleno Therapeutics announced that Neurocrine has entered into a definitive agreement to acquire Soleno for $53.00 per share in cash, representing a total transaction equity value of $2.9 billion. Wilson Sonsini Goodrich & Rosati is advising Soleno on the transaction.

Learn More

Client Highlights

On August 11, 2025, SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, announced it has raised $140 million in private financing, including $25 million in the second tranche of its Series C financing and $115 million in Series D financing, co-led by Elevage Medical Technologies and Ally Bridge Group. Wilson Sonsini Goodrich & Rosati advised SetPoint Medical on the transaction.

Learn More